|
Ivermectin treatment coverage of the eligible population (1995–1999) and LF antigenemia (1999) among male residents in five ivermectin treated villages, with 1999 LF antigenemia in one untreated village (Gwamlar) |
||||||
| Village |
Angwan Lemu |
Apanda |
Bakin-Kogi |
Lankan |
Mungkohot |
Gwamlar |
|
|
||||||
| Ivermectin rounds |
2 |
2 |
2 |
5 |
5 |
- |
| Mean coverage (range) |
91.4% (91–92) |
66.9% (58–76) |
85.3% (82–89) |
85.9% (65–95) |
77% (73–80) |
- |
| 1999 coverage |
92% |
58% |
89% |
90% |
80% |
- |
| % LF antigenemia in males (n) |
40% (30) |
43% (30) |
27% (30) |
47% (30) |
47% (30) |
58% (50) |
Richards et al. Filaria Journal 2005 4:6 doi:10.1186/1475-2883-4-6 |
||||||